Bryn Mawr Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$203K Buy
2018
Q1
Sell
2017
Q4
$5.16M Hold
2017
Q3
$5.16M Hold
2017
Q2
$5.67M Sell
2017
Q1
$4.5M Buy